Anantha Krishnan Dhanabalan

Thiosemicarbazone(s)-anchored water soluble mono- and bimetallic Cu(<scp>ii</scp>) complexes: enzyme-like activities, biomolecular interactions, anticancer property and real-time live cytotoxicity

Nithya Balakrishnan, Jebiti Haribabu, Anantha Krishnan Dhanabalan et al. · Dalton Transactions · 2020 · 75 citations

Natural Sciences, Biochemistry, Chemistry +17

Piperazine-substituted derivatives of favipiravir for Nipah virus inhibition: What do in silico studies unravel?

Raju Lipin, Anantha Krishnan Dhanabalan, K. Gunasekaran et al. · SN Applied Sciences · 2021 · 39 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Identification of potential PKC inhibitors through pharmacophore designing, 3D-QSAR and molecular dynamics simulations targeting Alzheimer’s disease

Saleem Iqbal, Anantha Krishnan Dhanabalan, K. Gunasekaran · Journal of Biomolecular Structure and Dynamics · 2017 · 27 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17

Screening of potential drug for Alzheimer’s disease: a computational study with GSK-3 β inhibition through virtual screening, docking, and molecular dynamics simulation

Nandha Devi Elangovan, Anantha Krishnan Dhanabalan, K. Gunasekaran et al. · Journal of Biomolecular Structure and Dynamics · 2020 · 27 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17

Purification, identification and in silico models of alkaloids from Nardostachys jatamansi — bioactive compounds for neurodegenerative diseases

Nagasathiya Krishnan, M. Vairamani, Anantha Krishnan Dhanabalan et al. · Biomass Conversion and Biorefinery · 2022 · 26 citations

Life Sciences, Neuroscience, Pharmacology +16